ロード中...
Emerging epigenetic-modulating therapies in lymphoma
Despite considerable advances in the treatment of lymphoma, the prognosis of patients with relapsed and/or refractory disease continues to be poor; thus, a continued need exists for the development of novel approaches and therapies. Epigenetic dysregulation might drive and/or promote tumorigenesis i...
保存先:
| 出版年: | Nat Rev Clin Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6650343/ https://ncbi.nlm.nih.gov/pubmed/30837715 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-019-0190-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|